S838 Health-Related Quality of Life in Patients With One Prior Episode of Recurrent Clostridioides difficile Infection (rCDI): Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled rCDI Trial (PUNCH CD3). (October 2022) - Dubberke, Erik R.; Guo, Amy; Harvey, Adam; Yang, Min; Garcia-Horton, Viviana; Fillbrunn, Mirko; Salcedo, Jonathan; Tillotson, Glenn; Bancke, Lindy; Garey, Kevin W.